Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018)

Clinical trial NCT01453634 · WITHDRAWN

Trial details

NCT number: NCT01453634
Sponsor: OPKO Health, Inc.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Stage 5 Chronic Kidney Disease (CKD)Secondary Hyperparathyroidism (SHPT)Hemodialysis (HD)

Start date: 2013-01-01
Primary completion: 2013-07-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.